Work overview

Section 21 of 37

DOSAGE AND DURATION OF ADMINISTRATION

Mechanistic insights into probiotic modulation of the gut–immune axis and their role as sustainable antibiotic alternatives in poultry production: An integrative review

Andreas Berny Yulianto, Aswin Rafif Khairullah, Widya Paramita Lokapirnasari, Mohammad Anam Al-Arif, Zulfi Nur Amrina Rosyada, Emy Koestanti Sabdoningrum, Bodhi Agustono, Mirni Lamid, Kartika Purnamasari, Bima Putra Pratama, Riza Zainuddin Ahmad, Wasito Wasito, Saifur Rehman, and Muhammad Aviv Firdaus · 2026

Contents

Section 21 of 37

  1. 01INTRODUCTION
  2. 02REVIEW METHODOLOGY
  3. 03BASIC CONCEPTS OF PROBIOTICS IN POULTRY
  4. 04DEFINITION OF PROBIOTICS
  5. 05TYPES AND SOURCES OF PROBIOTICS FOR POULTRY
  6. 06STRAIN-SPECIFIC EFFECTS AND QUANTITATIVE EVIDENCE
  7. 07GENERAL MECHANISMS OF PROBIOTICS IN THE DIGESTIVE TRACT
  8. 08IMMUNE SYSTEM IN POULTRY
  9. 09MUCOSAL IMMUNITY (GALT)
  10. 10INNATE IMMUNITY
  11. 11ADAPTIVE IMMUNITY
  12. 12GUT–IMMUNE AXIS RELATIONSHIP IN POULTRY
  13. 13THE EFFECT OF PROBIOTICS ON POULTRY IMMUNITY
  14. 14PROBIOTICS IN INCREASING INNATE IMMUNITY
  15. 15PROBIOTICS AND ADAPTIVE IMMUNITY
  16. 16EFFECTS ON MAJOR IMMUNE ORGANS
  17. 17PROBIOTICS IN REDUCING STRESS AND INFLAMMATION
  18. 18PROBIOTIC–MICROBIOTA INTERACTIONS IN SUPPORTING IMMUNITY
  19. 19THE EFFECT OF PROBIOTICS ON DISEASE RESISTANCE IN POULTRY
  20. 20FACTORS THAT INFLUENCE THE SUCCESS OF PROBIOTICS
  21. 21DOSAGE AND DURATION OF ADMINISTRATION
  22. 22DOSAGE FORM
  23. 23STABILITY AND RESISTANCE TO PH AND TEMPERATURE
  24. 24COMBINATION WITH PREBIOTICS (SYNBIOTICS)
  25. 25BACTERIAL STRAINS USED
  26. 26IN OVO AND EARLY-LIFE PROBIOTIC ADMINISTRATION
  27. 27CHALLENGES AND LIMITATIONS OF PROBIOTIC USE
  28. 28IMPLICATIONS FOR THE POULTRY INDUSTRY
  29. 29MARKET TRENDS AND REGIONAL ADOPTION PATTERNS
  30. 30SHORT-TERM APPLICABLE STRATEGIES FOR INDUSTRY IMPLEMENTATION
  31. 31ILLUSTRATIVE COMMERCIAL CASE EXAMPLES
  32. 32LONG-TERM RESEARCH AND DEVELOPMENT GOALS
  33. 33EMERGING ANALYTICAL APPROACHES
  34. 34FURTHER RESEARCH DIRECTIONS
  35. 35CONCLUSION
  36. 36GENERATIVE ARTIFICIAL INTELLIGENCE DECLARATION
  37. 37AUTHORS’ CONTRIBUTIONS
Text size
Work overview

Section 21 of 37

DOSAGE AND DURATION OF ADMINISTRATION

Andreas Berny Yulianto, Aswin Rafif Khairullah, Widya Paramita Lokapirnasari, Mohammad Anam Al-Arif, Zulfi Nur Amrina Rosyada, Emy Koestanti Sabdoningrum, Bodhi Agustono, Mirni Lamid, Kartika Purnamasari, Bima Putra Pratama, Riza Zainuddin Ahmad, Wasito Wasito, Saifur Rehman, and Muhammad Aviv Firdaus · about 1 minutes

The effectiveness of probiotics in supporting poultry health and immunity depends heavily on the dosage and duration of administration [80]. Appropriate dosing is crucial for stabilizing beneficial microbial populations in the digestive tract, enabling them to compete with pathogens, produce bioactive metabolites, and effectively modulate the immune system [216]. Dosage is typically determined by the type of probiotic, the age of the poultry, environmental conditions, and the intended purpose, such as enhancing growth, strengthening mucosal immunity, or improving the response to vaccination [217].

The duration of probiotic administration also plays a significant role [218]. Short-term administration may be sufficient to trigger a temporary immune response, but long-term supplementation has been shown to be more effective in establishing a stable gut microbiota balance, increasing mucosal antibody (IgA) production, and strengthening innate and adaptive immunity [219]. Research shows that administering probiotics early in life in birds can stimulate the development of lymphoid organs, such as the bursa of Fabricius, thymus, and spleen, thus supporting optimal immune system maturation [220].

Furthermore, administering probiotics at too low a dose may have only a minimal effect, whereas administering too high a dose does not always confer benefits and can disrupt the microbiota balance [221]. From a cost–benefit standpoint, identifying the minimal effective dose is essential to avoid unnecessary product expenditure without proportional performance gains. Non-linear dose–response patterns suggest that increasing dosage beyond the optimal threshold may increase cost without improving biological outcomes [222]. This approach aims to ensure probiotics provide optimal benefits in improving health, disease resistance, and sustainable poultry production performance [223].